5 employees
Eumentis is a biopharmaceutical company developing treatments for neuropsychiatric conditions.
2019
$3.9M
from 3 investors over 3 rounds
Eumentis Therapeutics Inc. raised $3.9M on September 30, 2020
Investors: Social Starts and Joyance Partners
Eumentis Therapeutics Inc. raised undisclosed on January 1, 2020
Investors: Life Science Angels